Jefferies upgraded PeptiDream to Buy from Hold with a price target of 1,600 yen, down from 1,900 yen. The analyst says the company seems likely to book a strong Q3 on the back of milestone and upfront payments from Merck, Astellas and Genentech.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>